UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
001-35560
ImmunoCellular Therapeutics, Ltd.
(Exact name of registrant as specified in its charter)
30721 Russell
Ranch Road, Suite 140
West Lake Village, California 91362
Telephone: (818)
264-2300
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, par value $0.0001 per share
Warrants to purchase Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule
12g-4(a)(1)
|
|
☒
|
Rule
12g-4(a)(2)
|
|
☐
|
Rule
12h-3(b)(1)(i)
|
|
☒
|
Rule
12h-3(b)(1)(ii)
|
|
☐
|
Rule
15d-6
|
|
☐
|
Rule
15d-22(b)
|
|
☐
|
Approximate number of holders of record as of the certification or notice date:
Common Stock, par value $0.0001 per share: 42 holders
Warrants to purchase Common Stock, par value $0.0001 per share: 27 holders